NCT04864847View on ClinicalTrials.gov

Clinical Validation of the RENISCHEM L-FABP POC Assay

RecruitingOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
Acute Kidney InjuryContrast-induced Nephropathy
Interventions
DIAGNOSTIC_TEST

RENISCHEM L-FABP POC Test

Point-of-care test cassette with quantitative reader used for the measurement of L-type fatty acid binding protein (L-FABP) in human urine specimens.

Trial Locations (6)

21215

RECRUITING

Sinai Hospital of Baltimore, Baltimore

32209

RECRUITING

University of Florida at Jacksonville, Jacksonville

33756

RECRUITING

Clearwater Cardiovascular Consultants, Clearwater

73104

RECRUITING

University of Oklahoma, Oklahoma City

85224

RECRUITING

Chandler Regional Medical Center, Chandler

94520

RECRUITING

John Muir Health, Concord

All Listed Sponsors
collaborator

Timewell Medical Co., Ltd.

UNKNOWN

lead

Hikari Dx, Inc.

OTHER